Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
pretty shivery; fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 25-OCT-2025, the patient received Shingles vaccine. In OCT-2025, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: fever) and shivers (Verbatim: pretty shivery). In OCT-2025, the outcome of the shivers was not resolved. The outcome of the fever was not resolved. It was unknown if the reporter considered the fever and shivers to be related to Shingles vaccine. It was unknown if the company considered the fever and shivers to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 25-OCT-2025 The patient reported receiving a shingles vaccine yesterday at a local pharmacy and was currently experiencing a fever of approximately 100.5 degree along with chills. The batch number was not provided, and we are unable to contact the reporter.
Test Name: Body temperature; Result Unstructured Data: (Test Result:100.5,Unit:degree C,Normal Low:,Normal High:)